R/R DLBCL: Safety Considerations for Bispecific Antibodies :

A comprehensive overview of safety considerations for bispecific antibodies in patients treated for R/R DLBCL.

Related Keywords

, New Treatment Options , Sequencing Therapeutic Choices , Safety Considerations , Lymphoma , Dlbcl , Diffuse Largeb Cell Lymphoma , Dlbcl Treatments , Dlbcl Therapies , Dlbcl Unmet Needs ,